ストックスクリーナーアプリを入手
358.93
2.04%
-7.46
アフターアワーズ：
365.00
6.07
+1.69%
前日終値:
$366.39
開ける：
$372.34
24時間の取引高:
242.93K
Relative Volume:
0.79
時価総額：
$16.02B
収益：
$2.76B
当期純損益:
$1.11B
株価収益率:
15.76
EPS:
22.77
ネットキャッシュフロー:
$898.10M
1週間 パフォーマンス:
-1.65%
1か月 パフォーマンス:
-5.47%
6か月 パフォーマンス:
+8.29%
1年 パフォーマンス:
+61.50%
1日の値動き範囲:
$357.25
$372.34
1週間の範囲:
$357.25
$372.34
52週間の値動き範囲:
$208.62
$417.81
United Therapeutics Corp Stock (UTHR) Company Profile
名前
United Therapeutics Corp
セクター
電話
(301) 608-9292
住所
1000 SPRING ST, SILVER SPRING, MD
UTHR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
UTHR
United Therapeutics Corp
|
358.93 | 16.02B | 2.76B | 1.11B | 898.10M | 22.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.00 | 108.68B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.58 | 74.90B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
640.52 | 38.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.27 | 31.76B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
111.93 | 26.83B | 3.30B | -501.07M | 1.03B | -2.1146 |
United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-11 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-02-12 | アップグレード | Goldman | Sell → Neutral |
| 2024-02-05 | 開始されました | Leerink Partners | Outperform |
| 2023-12-08 | 開始されました | Wells Fargo | Overweight |
| 2022-12-06 | 開始されました | UBS | Buy |
| 2022-12-05 | 開始されました | Goldman | Sell |
| 2022-10-11 | 開始されました | Morgan Stanley | Overweight |
| 2022-09-20 | 繰り返されました | BofA Securities | Underperform |
| 2022-09-19 | 再開されました | Wedbush | Outperform |
| 2022-02-11 | 開始されました | BTIG Research | Neutral |
| 2021-07-14 | アップグレード | Argus | Hold → Buy |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2021-02-01 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-09-14 | 再開されました | JP Morgan | Overweight |
| 2020-06-25 | 繰り返されました | H.C. Wainwright | Neutral |
| 2020-03-10 | アップグレード | Jefferies | Hold → Buy |
| 2020-02-27 | アップグレード | Cowen | Market Perform → Outperform |
| 2020-01-31 | アップグレード | JP Morgan | Neutral → Overweight |
| 2019-12-03 | 開始されました | BofA/Merrill | Underperform |
| 2019-08-01 | アップグレード | Jefferies | Underperform → Hold |
| 2019-08-01 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2019-07-01 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2019-05-17 | アップグレード | UBS | Sell → Neutral |
| 2019-05-09 | アップグレード | Credit Suisse | Underperform → Neutral |
| 2018-10-12 | アップグレード | Standpoint Research | Hold → Buy |
| 2018-08-08 | ダウングレード | Credit Suisse | Neutral → Underperform |
| 2018-04-03 | アップグレード | Credit Suisse | Underperform → Neutral |
| 2018-02-22 | 繰り返されました | Barclays | Underweight |
| 2018-01-18 | 再開されました | Credit Suisse | Underperform |
| 2017-12-27 | 繰り返されました | Wedbush | Outperform |
| 2017-04-27 | 繰り返されました | Wedbush | Outperform |
| 2017-03-30 | 開始されました | UBS | Sell |
| 2017-03-16 | 開始されました | Credit Suisse | Underperform |
すべてを表示
United Therapeutics Corp (UTHR) 最新ニュース
Manchester gets offer from United Therapeutics to buy nearly 350 acres in Hackett Hill area - AOL
United Therapeutics Corporation (NASDAQ:UTHR) Doing What It Can To Lift Shares - Simply Wall St
Wedge Capital Management L L P NC Has $28.03 Million Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Assenagon Asset Management S.A. Sells 8,067 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
USA Financial Formulas Has $307,000 Stake in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics (NASDAQ:UTHR) Upgraded to Strong-Buy at StockNews.com - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Short Interest Update - MarketBeat
Wedmont Private Capital Acquires Shares of 1,276 United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
UTHR: 3 Niche Biotech Stocks Redefining Innovation - StockNews.com
Burney Co. Raises Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) COO Sells $3,646,200.00 in Stock - MarketBeat
United Therapeutics president sells $3.65 million in stock By Investing.com - Investing.com Australia
United Therapeutics president sells $3.65 million in stock - Investing.com India
Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight - GlobeNewswire Inc.
United Therapeutics to Present at J.P. Morgan Conference - TipRanks
United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Nordea Investment Management AB - MarketBeat
Here's Why United Therapeutics (UTHR) is a Strong Growth Stock - Yahoo Finance
Here's Why United Therapeutics (UTHR) is a Strong Value Stock - Yahoo Finance
Are Medical Stocks Lagging United Therapeutics (UTHR) This Year? - Yahoo Finance
7 Best Biotech Stocks to Buy for 2025 | Investing - U.S News & World Report Money
United Therapeutics president Michael Benkowitz sells $3.55 million in stock By Investing.com - Investing.com Australia
United Therapeutics president Michael Benkowitz sells $3.55 million in stock - Investing.com India
United Therapeutics snaps up another property near Silver Spring HQ - The Business Journals
CWA Asset Management Group LLC Makes New Investment in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics CEO to Present Business Update at J.P. Morgan Healthcare Conference - StockTitan
JPMorgan Chase & Co. Has $69 Million Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Insider Sell: Nilda Mesa Sells Shares of United Therapeutics Corp - GuruFocus.com
Nilda Mesa Sells 255 Shares of United Therapeutics Co. (NASDAQ:UTHR) Stock - MarketBeat
United Therapeutics president Michael Benkowitz sells $3.57 million in stock By Investing.com - Investing.com Canada
United Therapeutics director Mesa Nilda sells $90,720 in stock By Investing.com - Investing.com Nigeria
United Therapeutics director Mesa Nilda sells $90,720 in stock - Investing.com India
United Therapeutics president Michael Benkowitz sells $3.57 million in stock - Investing.com
We Ran A Stock Scan For Earnings Growth And United Therapeutics (NASDAQ:UTHR) Passed With Ease - Yahoo Finance
United Therapeutics Corporation (UTHR): Among the Cheap Healthcare Stocks to Buy Heading Into 2025 - Insider Monkey
United Therapeutics president Michael Benkowitz sells $3.6m in stock - Investing.com India
Insider Selling: United Therapeutics Co. (NASDAQ:UTHR) COO Sells 10,000 Shares of Stock - MarketBeat
United Therapeutics president Michael Benkowitz sells $3.6m in stock By Investing.com - Investing.com UK
Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term - Yahoo Finance
Here are Updates on United Therapeutics Corp. (UTHR) - MSN
Is United Therapeutics (UTHR) the Best Performing Biotech Stock in 2024? - Yahoo Finance
Principal Financial Group Inc. Has $40.31 Million Stake in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Why United Therapeutics (UTHR) is a Top Value Stock for the Long-Term - Yahoo Finance
Insider Sell: Louis Sullivan Sells 26,209 Shares of United Thera - GuruFocus.com
United Therapeutics Co. (NASDAQ:UTHR) Director Sells $9,781,722.98 in Stock - MarketBeat
United Therapeutics director sells shares worth $9.78 million - Investing.com
United Therapeutics president and COO sells $3.7 million in stock - Investing.com India
United Therapeutics (NASDAQ:UTHR) Trading Down 4.4%Here's Why - MarketBeat
United Therapeutics Corp (UTHR) 財務データ
収益
当期純利益
現金流量
EPS
United Therapeutics Corp (UTHR) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| BENKOWITZ MICHAEL | PRESIDENT AND COO |
Jan 13 '25 |
Option Exercise |
111.00 |
10,000 |
1,110,000 |
7,500 |
| BENKOWITZ MICHAEL | PRESIDENT AND COO |
Jan 13 '25 |
Sale |
364.62 |
10,000 |
3,646,223 |
0 |
| PATUSKY CHRISTOPHER | Director |
Jan 10 '25 |
Option Exercise |
175.43 |
5,000 |
877,150 |
5,900 |
| PATUSKY CHRISTOPHER | Director |
Jan 10 '25 |
Sale |
361.61 |
5,000 |
1,808,072 |
900 |
4.62%
0.75%
大文字化:
|
ボリューム (24 時間):